Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets

European Psychiatry

Volumn 22, Issue 7, 2007, Pages 453-454

  Crocq, Marc Antoine ^a   Guillon, Marie Sa ^a   Bailey, Paul Ernest ^a   Provost, Dominique ^a  

^a Centre Hospitalier de Rouffach   (France)

Author keywords

Adolescents; BMI; Olanzapine; Orally disintegrating tablets; Weight gain

Indexed keywords

OLANZAPINE; RISPERIDONE;

ADOLESCENT; ARTICLE; BODY MASS; CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; SATIETY; SCHIZOPHRENIFORM DISORDER; SIDE EFFECT; TABLET FORMULATION; WEIGHT GAIN;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; BODY WEIGHT; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; MALE; RISPERIDONE; SCHIZOPHRENIA; TABLETS; WEIGHT GAIN;

EID: 35348992825     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.06.004     Document Type: Article

References (5)

1. Arranz B., San L., Dueñas R.M., Centeno M., Ramirez N., Salavert J., et al. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients. Hum Psychopharmacol Clin Exp 22 (2007) 11-15
2. De Haan L., van Amelsvoort T., Rosien K., and Linszen D. Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets. Psychopharmacology 175 (2004) 389-390
3. 2-like receptor. Am J Physiol Regul Integr Comp Physiol 266 (1994) 284-291
4. Markowitz J.S., DeVane C.L., Malcolm R.J., Gefroh H.A., Wang J.S., Zhu H.J., et al. Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers. J Clin Pharmacol 46 (2006) 164-171
5. 2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 15 (2005) 195-200